GI side effects usually stabilize during this phase
Finally, the efficacy and safety of subcutaneous semaglutide varied depending on treatment dosage, administration frequency, trial duration, baseline obesity level and whether accompanied with lifestyle intervention
Semaglutide 10mg is a widely studied GLP-1 receptor agonist used in research focused on metabolic regulation, appetite signaling, and glucose control
When guiding patients, it can be helpful to frame the conversation around three questions: What fits best into your daily routine
The higher dose ceiling means Wegovy can produce greater average weight loss than Ozempic, with trials showing up to 15% of body weight lost over 68 weeks
It depends on your risk and the procedure